Clinical trial · Observational
Study of 18F-FAPI Applied to Gastrointestinal Cancer
Comparative Study of 18F-FAPI and 18F-FDG PET/CT for Gastrointestinal Cancer
NCT05788874CI-TRIAL-00065668unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Comparison of tumor volume, number, and SUVmax of different primary foci (gastric, duodenal, and colon cancer), lymph node metastases (neck and supraclavicular, mediastinal, abdominal, and pelvic), and distant metastases (brain, lung, liver, bone, pleura, and peritoneum) detected by 18F-FAPI versus 18F-FDG PET/CT imaging.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastrointestinal Cancer | Malignant Digestive System Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 18F-FAPI and 18F-FDG PET/CT | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- 18F-FDG
- interventionNames
- Diagnostic Test: 18F-FAPI and 18F-FDG PET/CT
- label
- 18F-FAPI
- interventionNames
- Diagnostic Test: 18F-FAPI and 18F-FDG PET/CT
Primary outcomes (1)
- measure
- SUVmax
- timeFrame
- 1 day (During the inspection)
- description
- Measurement of the maximum standardized uptake value of the lesion
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with high clinical suspicion of gastrointestinal tumor and negative 18F-FDG at first diagnosis * Post-treatment patients with high clinical suspicion of recurrence or metastasis and negative 18F-FDG Exclusion Criteria: * The diagnosis can be clarified by 18F-FDG PET/CT examination * The presence of recurrence or metastasis can be clarified by 18F-FDG PET/CT examination
References
Publications (0)
Data not yet available
No reference posted for this study.